Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. (se deschide o fereastră nouă)

CRASH-3 Trial Collaborators

Sursă‎: Lancet 2019;394(10210):1713-23.

Index‎: PubMed 31623894

DOI‎: 10.1016/S0140-6736(19)32233-0

https://www.ncbi.nlm.nih.gov/pubmed/31623894 (se deschide o fereastră nouă)

Alternatives to allogeneic platelet transfusion. (se deschide o fereastră nouă)

Desborough MJ, Smethurst PA, Estcourt LJ, Stanworth SJ.

Sursă‎: Br J Haematol 2016;175(3):381-92.

Index‎: PubMed 27650431

DOI‎: 10.1111/bjh.14338

https://www.ncbi.nlm.nih.gov/pubmed/27650431 (se deschide o fereastră nouă)

Tranexamic acid: less bleeding and less thrombosis? (se deschide o fereastră nouă)

Godier A, Roberts I, Hunt BJ.

Sursă‎: Crit Care 2012;16(3):135.

Index‎: PubMed 22748073

DOI‎: 10.1186/cc11374

https://www.ncbi.nlm.nih.gov/pubmed/22748073 (se deschide o fereastră nouă)

Tranexamic acid for reducing mortality in emergency and urgent surgery. (se deschide o fereastră nouă)

Perel P, Ker K, Morales Uribe CH, Roberts I

Sursă‎: Cochrane Database Syst Rev 2013;(1):CD010245.

Index‎: PubMed 23440847

DOI‎: 10.1002/14651858.CD010245.pub2

https://www.ncbi.nlm.nih.gov/pubmed/23440847 (se deschide o fereastră nouă)

The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. (se deschide o fereastră nouă)

Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y, Gando S, Guyatt G, Hunt BJ, Morales C, Perel P, Prieto-Merino D, Woolley T; CRASH-2 collaborators.

Sursă‎: Lancet 2011;377(9771):1096-101, 1101.e1-2.

Index‎: PubMed 21439633

DOI‎: 10.1016/S0140-6736(11)60278-X

https://www.ncbi.nlm.nih.gov/pubmed/21439633 (se deschide o fereastră nouă)

Antifibrinolytic drugs for acute traumatic injury. (se deschide o fereastră nouă)

Roberts I, Shakur H, Ker K, Coats T; CRASH‐2 Trial collaborators.

Sursă‎: Cochrane Database Syst Rev 2011;(1):CD004896.

Index‎: PubMed 21249666

DOI‎: 10.1002/14651858.CD004896.pub3

https://www.ncbi.nlm.nih.gov/pubmed/21249666 (se deschide o fereastră nouă)

Use of tranexamic acid to reduce bleeding in burns surgery. (se deschide o fereastră nouă)

Tang YM, Chapman TW, Brooks P

Sursă‎: J Plast Reconstr Aesthet Surg 2012;65(5):684-6.

Index‎: PubMed 21983540

DOI‎: 10.1016/j.bjps.2011.09.028

https://www.ncbi.nlm.nih.gov/pubmed/21983540 (se deschide o fereastră nouă)

Tranexamic acid reduced blood transfusions in acute burn surgery: a retrospective case-controlled trial. (se deschide o fereastră nouă)

Tapking C, Hundeshagen G, Kirchner M, Fischer S, Kneser U, Bliesener B

Sursă‎: Burns. 2022;48(3):522-28.

Index‎: PubMed 35339324

DOI‎: 10.1016/j.burns.2022.03.002

https://pubmed.ncbi.nlm.nih.gov/35339324/ (se deschide o fereastră nouă)

Salvage use of activated recombinant factor VII in the management of refractory bleeding following cardiac surgery. (se deschide o fereastră nouă)

Barua A, Rao VP, Ramesh B, Barua B, El-Shafei H.

Sursă‎: J Blood Med 2011;2:131-4.

Index‎: PubMed 22287872

DOI‎: 10.2147/JBM.S21609

https://www.ncbi.nlm.nih.gov/pubmed/22287872 (se deschide o fereastră nouă)

The treatment of bleeding is to stop the bleeding! Treatment of trauma-related hemorrhage. (se deschide o fereastră nouă)

Boffard KD, Choong PI, Kluger Y, Riou B, Rizoli SB, Rossaint R, Warren B; NovoSeven Trauma Study Group.

Sursă‎: Transfusion 2009;49 Suppl 5:240S-7S.

Index‎: PubMed 19954486

DOI‎: 10.1111/j.1537-2995.2008.01987.x

https://www.ncbi.nlm.nih.gov/pubmed/19954486 (se deschide o fereastră nouă)

The early use of fibrinogen, prothrombin complex concentrate, and recombinant-activated factor VIIa in massive bleeding. (se deschide o fereastră nouă)

Fries D

Sursă‎: Transfusion 2013;53 Suppl 1:91S-5S.

Index‎: PubMed 23301979

DOI‎: 10.1111/trf.12041

https://www.ncbi.nlm.nih.gov/pubmed/23301979 (se deschide o fereastră nouă)

A Jehovah's Witness with complex abdominal trauma and coagulopathy: use of factor VII and a review of the literature. (se deschide o fereastră nouă)

Haan J, Scalea T

Sursă‎: Am Surg 2005;71(5):414-5.

Index‎: PubMed 15986972

https://www.ncbi.nlm.nih.gov/pubmed/15986972 (se deschide o fereastră nouă)

Results of the control trial: efficacy and safety of recombinant activated factor VII in the management of refractory traumatic hemorrhage. (se deschide o fereastră nouă)

Hauser CJ, Boffard K, Dutton R, Bernard GR, Croce MA, Holcomb JB, Leppaniemi A, Parr M, Vincent JL, Tortella BJ, Dimsits J, Bouillon B; CONTROL Study Group.

Sursă‎: J Trauma 2010;69(3):489-500.

Index‎: PubMed 20838118

DOI‎: 10.1097/TA.0b013e3181edf36e

https://www.ncbi.nlm.nih.gov/pubmed/20838118 (se deschide o fereastră nouă)

Use of recombinant activated factor VII in patients without hemophilia: a meta-analysis of randomized control trials. (se deschide o fereastră nouă)

Hsia CC, Chin-Yee IH, McAlister VC.

Sursă‎: Ann Surg 2008;248(1):61-8.

Index‎: PubMed 18580208

DOI‎: 10.1097/SLA.0b013e318176c4ec

https://www.ncbi.nlm.nih.gov/pubmed/18580208 (se deschide o fereastră nouă)

Rescue treatment with recombinant factor VIIa is effective in patients with life-threatening bleedings secondary to major wound excision: a report of four cases. (se deschide o fereastră nouă)

Johansson PI, Eriksen K, Alsbjørn B

Sursă‎: J Trauma 2006;61(4):1016-8.

Index‎: PubMed 17033583

DOI‎: 10.1097/01.ta.0000239261.48022.f1

https://www.ncbi.nlm.nih.gov/pubmed/17033583 (se deschide o fereastră nouă)

Use of recombinant activated factor VII in Jehovah's Witness patients with critical bleeding. (se deschide o fereastră nouă)

Kandane-Rathnayake RK, Isbister JP, Zatta AJ, Aoki NJ, Cameron P, Phillips LE; Australian and New Zealand Haemostasis Registry Steering Committee

Sursă‎: ANZ J Surg 2013;83(3):155-60.

Index‎: PubMed 23035873

DOI‎: 10.1111/j.1445-2197.2012.06285.x

https://www.ncbi.nlm.nih.gov/pubmed/23035873 (se deschide o fereastră nouă)

Recombinant factor VIIa in trauma patients with the 'triad of death.' (se deschide o fereastră nouă)

Mitra B, Cameron PA, Parr MJ, Phillips L.

Sursă‎: Injury 2012;43(9):1409-14.

Index‎: PubMed 21345431

DOI‎: 10.1016/j.injury.2011.01.033

https://www.ncbi.nlm.nih.gov/pubmed/21345431 (se deschide o fereastră nouă)

Low-dose recombinant factor VIIa for trauma patients with coagulopathy. (se deschide o fereastră nouă)

Stein DM, Dutton RP, Hess JR, Scalea TM.

Sursă‎: Injury 2008;39(9):1054-61.

Index‎: PubMed 18656871

DOI‎: 10.1016/j.injury.2008.03.032

https://www.ncbi.nlm.nih.gov/pubmed/18656871 (se deschide o fereastră nouă)

Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (Novoseven®). (se deschide o fereastră nouă)

Tanaka KA, Waly AA, Cooper WA, Levy JH.

Sursă‎: Anesthesiology 2003;98(6):1513-5.

Index‎: PubMed 12766668

https://www.ncbi.nlm.nih.gov/pubmed/12766668 (se deschide o fereastră nouă)

Alternatives to allogeneic platelet transfusion. (se deschide o fereastră nouă)

Desborough MJ, Smethurst PA, Estcourt LJ, Stanworth SJ.

Sursă‎: Br J Haematol 2016;175(3):381-92.

Index‎: PubMed 27650431

DOI‎: 10.1111/bjh.14338

https://www.ncbi.nlm.nih.gov/pubmed/27650431 (se deschide o fereastră nouă)

The early use of fibrinogen, prothrombin complex concentrate, and recombinant-activated factor VIIa in massive bleeding. (se deschide o fereastră nouă)

Fries D

Sursă‎: Transfusion 2013;53 Suppl 1:91S-5S.

Index‎: PubMed 23301979

DOI‎: 10.1111/trf.12041

https://www.ncbi.nlm.nih.gov/pubmed/23301979 (se deschide o fereastră nouă)

Plasma fibrinogen level on admission to the intensive care unit is a powerful predictor of postoperative bleeding after cardiac surgery with cardiopulmonary bypass. (se deschide o fereastră nouă)

Kindo M, Hoang Minh T, Gerelli S, Perrier S, Meyer N, Schaeffer M, Bentz J, Announe T, Mommerot A, Collange O, Pottecher J, Cristinar M, Thiranos JC, Gros H, Mertes PM, Billaud P, Mazzucotelli JP

Sursă‎: Thromb Res 2014;134(2):360-8.

Index‎: PubMed 24857189

DOI‎: 10.1016/j.thromres.2014.05.008

https://www.ncbi.nlm.nih.gov/pubmed/24857189 (se deschide o fereastră nouă)

Combination of recombinant factor VIIa and fibrinogen corrects clot formation in primary immune thrombocytopenia at very low platelet counts. (se deschide o fereastră nouă)

Larsen OH, Stentoft J, Radia D, Ingerslev J, Sørensen B

Sursă‎: Br J Haematol 2013;160(2):228-36.

Index‎: PubMed 23151086

DOI‎: 10.1111/bjh.12118

https://www.ncbi.nlm.nih.gov/pubmed/23151086 (se deschide o fereastră nouă)

Strategies to reduce the use of blood products: a European perspective. (se deschide o fereastră nouă)

Theusinger OM, Felix C, Spahn DR.

Sursă‎: Curr Opin Anaesthesiol 2012;25(1):59-65.

Index‎: PubMed 22113184

DOI‎: 10.1097/ACO.0b013e32834dec98

https://www.ncbi.nlm.nih.gov/pubmed/22113184 (se deschide o fereastră nouă)

Desmopressin reduces transfusion needs after surgery: a meta-analysis of randomized clinical trials. (se deschide o fereastră nouă)

Crescenzi G, Landoni G, Biondi-Zoccai G, Pappalardo F, Nuzzi M, Bignami E, Fochi O, Maj G, Calabrò MG, Ranucci M, Zangrillo A

Sursă‎: Anesthesiology 2008;109(6):1063-76.

Index‎: PubMed 19034103

DOI‎: 10.1097/ALN.0b013e31818db18b

https://www.ncbi.nlm.nih.gov/pubmed/19034103 (se deschide o fereastră nouă)

Alternatives to allogeneic platelet transfusion. (se deschide o fereastră nouă)

Desborough MJ, Smethurst PA, Estcourt LJ, Stanworth SJ.

Sursă‎: Br J Haematol 2016;175(3):381-92.

Index‎: PubMed 27650431

DOI‎: 10.1111/bjh.14338

https://www.ncbi.nlm.nih.gov/pubmed/27650431 (se deschide o fereastră nouă)

Desmopressin in treatment of haematological disorders and in prevention of surgical bleeding. (se deschide o fereastră nouă)

Svensson PJ, Bergqvist PB, Juul KV, Berntorp E

Sursă‎: Blood Rev 2014;28(3):95-102.

Index‎: PubMed 24703870

DOI‎: 10.1016/j.blre.2014.03.001

https://www.ncbi.nlm.nih.gov/pubmed/24703870 (se deschide o fereastră nouă)

Coagulopathy caused by vitamin K deficiency in critically ill, hospitalized patients. (se deschide o fereastră nouă)

Alperin JB

Sursă‎: JAMA 1987;258(14):1916-9.

Index‎: PubMed 3656602

DOI‎: 10.1001/jama.1987.03400140078028

https://www.ncbi.nlm.nih.gov/pubmed/3656602 (se deschide o fereastră nouă)

Vitamin K deficiency and D-dimer levels in the intensive care unit: a prospective cohort study. (se deschide o fereastră nouă)

Crowther MA, McDonald E, Johnston M, Cook D

Sursă‎: Blood Coagul Fibrinolysis 2002;13(1):49-52.

Index‎: PubMed 11994567

DOI‎: 10.1097/00001721-200201000-00007

https://www.ncbi.nlm.nih.gov/pubmed/11994567 (se deschide o fereastră nouă)

The use of fibrin sealant in burn operations. (se deschide o fereastră nouă)

Foster K

Sursă‎: Surgery 2007;142(4 Suppl):S50-4.

Index‎: PubMed 18019939

DOI‎: 10.1016/j.surg.2007.06.026

https://www.ncbi.nlm.nih.gov/pubmed/18019939 (se deschide o fereastră nouă)

Use of fibrin sealant in thermal injury. (se deschide o fereastră nouă)

McGill V, Kowal-Vern A, Lee M, Greenhalgh D, Gomperts E, Bray G, Gamelli R

Sursă‎: J Burn Care Rehabil 1997;18(5):429-34.

Index‎: PubMed 9313125

DOI‎: 10.1097/00004630-199709000-00011

https://www.ncbi.nlm.nih.gov/pubmed/9313125 (se deschide o fereastră nouă)

Perioperative treatment algorithm for bleeding burn patients reduces allogeneic blood product requirements. (se deschide o fereastră nouă)

Schaden E, Kimberger O, Kraincuk P, Baron DM, Metnitz PG, Kozek-Langenecker S

Sursă‎: Br J Anaesth 2012;109(3):376-81.

Index‎: PubMed 22719014

DOI‎: 10.1093/bja/aes186

https://www.ncbi.nlm.nih.gov/pubmed/22719014 (se deschide o fereastră nouă)

Transfusion in trauma: why and how should we change our current practice? (se deschide o fereastră nouă)

Theusinger OM, Spahn DR, Ganter MT.

Sursă‎: Curr Opin Anaesthesiol 2009;22(2):305-12.

Index‎: PubMed 19390257

DOI‎: 10.1097/ACO.0b013e3283212c7c

https://www.ncbi.nlm.nih.gov/pubmed/19390257 (se deschide o fereastră nouă)

Viscoelastic point-of-care testing to assist with the diagnosis, management and monitoring of haemostasis: a systematic review and cost-effectiveness analysis. (se deschide o fereastră nouă)

Whiting P, Al M, Westwood M, Ramos IC, Ryder S, Armstrong N, Misso K, Ross J, Severens J, Kleijnen J

Sursă‎: Health Technol Assess 2015;19(58):1-228.

Index‎: PubMed 26215747

DOI‎: 10.3310/hta19580

https://www.ncbi.nlm.nih.gov/pubmed/26215747 (se deschide o fereastră nouă)